Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oligodendroglia | 3 | 2018 | 120 | 0.710 |
Why?
|
| Pluripotent Stem Cells | 1 | 2018 | 36 | 0.600 |
Why?
|
| Cell Lineage | 1 | 2018 | 302 | 0.540 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2024 | 407 | 0.470 |
Why?
|
| Mutation | 5 | 2024 | 4204 | 0.280 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2024 | 429 | 0.220 |
Why?
|
| Laboratories | 1 | 2023 | 44 | 0.210 |
Why?
|
| Alleles | 2 | 2018 | 1141 | 0.200 |
Why?
|
| BRCA1 Protein | 1 | 2024 | 207 | 0.200 |
Why?
|
| Leukemia, B-Cell | 1 | 2022 | 23 | 0.190 |
Why?
|
| Public Health | 1 | 2023 | 145 | 0.190 |
Why?
|
| Loss of Function Mutation | 1 | 2021 | 47 | 0.180 |
Why?
|
| Socioeconomic Factors | 1 | 2024 | 611 | 0.180 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2021 | 105 | 0.180 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2022 | 164 | 0.180 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2022 | 187 | 0.170 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2018 | 131 | 0.160 |
Why?
|
| Paclitaxel | 1 | 2021 | 495 | 0.160 |
Why?
|
| Phenylalanine Hydroxylase | 1 | 2018 | 3 | 0.150 |
Why?
|
| Pelizaeus-Merzbacher Disease | 1 | 2018 | 1 | 0.150 |
Why?
|
| Oligodendrocyte Precursor Cells | 1 | 2018 | 3 | 0.150 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2018 | 31 | 0.150 |
Why?
|
| Lentivirus | 1 | 2018 | 44 | 0.150 |
Why?
|
| Genetic Engineering | 1 | 2018 | 117 | 0.140 |
Why?
|
| CRISPR-Cas Systems | 1 | 2018 | 86 | 0.140 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2021 | 622 | 0.140 |
Why?
|
| Myelin Sheath | 2 | 2018 | 82 | 0.140 |
Why?
|
| DNA Mutational Analysis | 1 | 2018 | 531 | 0.130 |
Why?
|
| Genetic Association Studies | 1 | 2018 | 294 | 0.130 |
Why?
|
| Early Detection of Cancer | 1 | 2020 | 469 | 0.130 |
Why?
|
| Mice, Knockout | 2 | 2018 | 2087 | 0.120 |
Why?
|
| Immunotherapy | 1 | 2021 | 725 | 0.120 |
Why?
|
| Cell Differentiation | 2 | 2018 | 1592 | 0.110 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2020 | 815 | 0.110 |
Why?
|
| Genotype | 1 | 2018 | 1863 | 0.110 |
Why?
|
| Intestinal Polyposis | 1 | 2013 | 2 | 0.110 |
Why?
|
| Genome, Human | 1 | 2018 | 799 | 0.110 |
Why?
|
| Biomarkers, Tumor | 1 | 2021 | 1576 | 0.100 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 1138 | 0.100 |
Why?
|
| Testicular Neoplasms | 1 | 2013 | 120 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 2394 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 3360 | 0.090 |
Why?
|
| Mice | 4 | 2018 | 12110 | 0.090 |
Why?
|
| Stem Cells | 1 | 2013 | 383 | 0.090 |
Why?
|
| Fibroblasts | 1 | 2013 | 767 | 0.080 |
Why?
|
| Humans | 13 | 2024 | 92337 | 0.080 |
Why?
|
| Neoplasm Proteins | 1 | 2013 | 547 | 0.080 |
Why?
|
| Neurons | 1 | 2018 | 1596 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 2394 | 0.080 |
Why?
|
| Male | 6 | 2024 | 43925 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 3053 | 0.070 |
Why?
|
| Genetic Testing | 2 | 2023 | 550 | 0.070 |
Why?
|
| Adult | 5 | 2024 | 27532 | 0.060 |
Why?
|
| Young Adult | 3 | 2024 | 6624 | 0.060 |
Why?
|
| Adolescent | 3 | 2024 | 9504 | 0.060 |
Why?
|
| Animals | 4 | 2018 | 28003 | 0.060 |
Why?
|
| Prognosis | 2 | 2024 | 3872 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2013 | 1684 | 0.060 |
Why?
|
| Female | 6 | 2024 | 47893 | 0.060 |
Why?
|
| Death, Sudden | 1 | 2023 | 40 | 0.050 |
Why?
|
| Autopsy | 1 | 2023 | 123 | 0.050 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2023 | 54 | 0.050 |
Why?
|
| Middle Aged | 4 | 2024 | 27030 | 0.050 |
Why?
|
| Germ Cells | 1 | 2024 | 132 | 0.050 |
Why?
|
| BRCA2 Protein | 1 | 2024 | 165 | 0.050 |
Why?
|
| Social Determinants of Health | 1 | 2024 | 105 | 0.050 |
Why?
|
| Mucin-4 | 1 | 2022 | 7 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2024 | 6916 | 0.050 |
Why?
|
| Chromosomal Instability | 1 | 2021 | 20 | 0.050 |
Why?
|
| Aged | 3 | 2024 | 19943 | 0.050 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2022 | 111 | 0.050 |
Why?
|
| Germ-Line Mutation | 1 | 2024 | 358 | 0.040 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2022 | 183 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2022 | 462 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2024 | 9703 | 0.040 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2018 | 86 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2022 | 1807 | 0.040 |
Why?
|
| Stomach Neoplasms | 1 | 2020 | 297 | 0.030 |
Why?
|
| Survival Rate | 1 | 2021 | 1927 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2018 | 274 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2018 | 696 | 0.030 |
Why?
|
| Cell Survival | 1 | 2018 | 1008 | 0.030 |
Why?
|
| Biomarkers | 1 | 2022 | 1850 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 3775 | 0.030 |
Why?
|
| Phenotype | 1 | 2020 | 2498 | 0.030 |
Why?
|
| Genetic Enhancement | 1 | 2013 | 2 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2018 | 2902 | 0.030 |
Why?
|
| Transcriptome | 1 | 2018 | 699 | 0.030 |
Why?
|
| Heterozygote | 1 | 2013 | 379 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2013 | 190 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2018 | 1392 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 2448 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2024 | 8740 | 0.020 |
Why?
|
| United States | 1 | 2024 | 7348 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2013 | 2037 | 0.020 |
Why?
|